Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer

Title
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
Authors
Keywords
non-small cell lung cancer; anti-PD-1/PD-L1 therapy; acquired resistance; immunotherapy; innate resistance
Journal
Oncotarget
Volume 9, Issue 4, Pages -
Publisher
Impact Journals, LLC
Online
2017-12-16
DOI
10.18632/oncotarget.23315

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search